Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-01 @ 2:47 AM
Study NCT ID:
NCT04067856
Status:
WITHDRAWN
Last Update Posted:
2021-02-21
First Post:
2019-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
Sponsor:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-22
First Submit QC Date:
None
Study First Post Date:
2019-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-17
Last Update Post Date:
2021-02-21
Last Update Post Date Type:
ACTUAL